Stifel Financial’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.09M | Buy |
42,950
+3,931
| +10% | +$191K | ﹤0.01% | 1828 |
|
|
2025
Q1 | $1.33M | Sell |
39,019
-4,109
| -10% | -$140K | ﹤0.01% | 2045 |
|
|
2024
Q4 | $1.7M | Buy |
43,128
+2,891
| +7% | +$114K | ﹤0.01% | 1895 |
|
|
2024
Q3 | $1.89M | Sell |
40,237
-10,175
| -20% | -$478K | ﹤0.01% | 1813 |
|
|
2024
Q2 | $2.72M | Sell |
50,412
-9,020
| -15% | -$487K | ﹤0.01% | 1513 |
|
|
2024
Q1 | $4.05M | Buy |
59,432
+4,580
| +8% | +$312K | ﹤0.01% | 1269 |
|
|
2023
Q4 | $3.43M | Buy |
54,852
+27,973
| +104% | +$1.75M | ﹤0.01% | 1321 |
|
|
2023
Q3 | $1.22M | Sell |
26,879
-1,982
| -7% | -$90K | ﹤0.01% | 1910 |
|
|
2023
Q2 | $1.62M | Sell |
28,861
-682
| -2% | -$38.3K | ﹤0.01% | 1773 |
|
|
2023
Q1 | $1.34M | Sell |
29,543
-420
| -1% | -$19K | ﹤0.01% | 1837 |
|
|
2022
Q4 | $1.22M | Buy |
29,963
+797
| +3% | +$32.4K | ﹤0.01% | 1853 |
|
|
2022
Q3 | $1.91M | Buy |
29,166
+6,070
| +26% | +$397K | ﹤0.01% | 1513 |
|
|
2022
Q2 | $1.4M | Sell |
23,096
-10,529
| -31% | -$640K | ﹤0.01% | 1747 |
|
|
2022
Q1 | $2.11M | Buy |
33,625
+4,234
| +14% | +$266K | ﹤0.01% | 1579 |
|
|
2021
Q4 | $2.23M | Sell |
29,391
-6,031
| -17% | -$457K | ﹤0.01% | 1532 |
|
|
2021
Q3 | $3.97M | Buy |
35,422
+13,004
| +58% | +$1.46M | 0.01% | 1151 |
|
|
2021
Q2 | $3.63M | Sell |
22,418
-72
| -0.3% | -$11.7K | 0.01% | 1203 |
|
|
2021
Q1 | $2.74M | Buy |
22,490
+5,689
| +34% | +$693K | ﹤0.01% | 1325 |
|
|
2020
Q4 | $2.57M | Buy |
16,801
+4,166
| +33% | +$638K | ﹤0.01% | 1237 |
|
|
2020
Q3 | $1.06M | Buy |
12,635
+742
| +6% | +$62.1K | ﹤0.01% | 1589 |
|
|
2020
Q2 | $874K | Sell |
11,893
-388
| -3% | -$28.5K | ﹤0.01% | 1659 |
|
|
2020
Q1 | $522K | Buy |
12,281
+719
| +6% | +$30.6K | ﹤0.01% | 1838 |
|
|
2019
Q4 | $705K | Buy |
11,562
+1,767
| +18% | +$108K | ﹤0.01% | 2050 |
|
|
2019
Q3 | $400K | Buy |
9,795
+1,491
| +18% | +$60.9K | ﹤0.01% | 2283 |
|
|
2019
Q2 | $399K | Buy |
+8,304
| New | +$399K | ﹤0.01% | 2323 |
|